🇺🇸 FDA
Patent

US 8263095

Methods of use for peptides having activities of insulin like growth factor-1

granted A61KA61K38/00A61P

Quick answer

US patent 8263095 (Methods of use for peptides having activities of insulin like growth factor-1) held by CAREGEN CO., LTD. expires Mon Sep 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
CAREGEN CO., LTD.
Grant date
Tue Sep 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K38/00, A61P, A61P1/02, A61P17/00